% | $
Quotes you view appear here for quick access.

MannKind Corp. Message Board

trade_pro101 87 posts  |  Last Activity: Apr 21, 2015 3:10 AM Member since: Mar 3, 2014
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • trade_pro101 trade_pro101 Apr 21, 2015 3:10 AM Flag

    I think MNKD will Crash Hard after the Q2 Earnings Report in 2 weeks. Look for an ENTRY at that point. Play the game... don't fall in love with the stock. My main reason to buy is banking on an eventual short squeeze with 35% Short Float. But I don't think Q2 will be the catalyst. One more strong leg down after Q2... then Load Up... or Powder Up.

  • October 2008: SVM $1.11 low at Silver $8.40 low........... April 2006: SVM $6.51 high at Silver $14.57 high...........April 2015: SVM $1.24 at Silver $16.25. = WAY OVERSOLD !!! This is definitely something to hold long from here on. Cheers to the Rebound :)

    Sentiment: Strong Buy

  • Reply to

    Very Strong Fundamentals ...

    by trade_pro101 Mar 27, 2015 12:15 AM
    trade_pro101 trade_pro101 Mar 28, 2015 10:38 PM Flag

    AV... 95% of people searching for a message board on a stock will just Google. I'm a member of Yahoo Message Board with login and all... and I never log into Yahoo to search a stock. I find it quicker to just Google the Stock Symbol + the words "message board" so I can read all message boards on that stock and not just Yahoo. Majority of investors thinking about SVM would Google it, because they'll want to read many message boards on it, such as Stockhouse as well. So according to what you said that you can still Google it and get to it, I believe 95% of retail investors would access it that way. As far a financial statement errors... I personally believe it's just a paranoia people have to find small errors that are probably there even with other large companies, but the other companies were not in the limelight regarding reporting errors. Also, people fear that's an issue for all companies in China. However, the reason I'm not worried about it, is because since the whole issue with the shorts falsifying information a few years ago, Silvercorp has been found innocent in New York courts as well as the Canadian Securities Commission found them innocent. They were scrutinized to the yin-yang the last few years and found innocent. That Hedge Fund was actually criminally charged for falsifying information to gain on shorting. I trust the U.S. and Canadian Securities Commissions over Hedge Funds that are motivated to falsify so they can gain money shorting. Put it this way AV... after being put in the limelight a few years ago... If something shady was going on with Silvercorp... they would have been shut down by now after close U.S. and Canadian scrutiny.

    Sentiment: Strong Buy

  • Reply to

    Very Strong Fundamentals ...

    by trade_pro101 Mar 27, 2015 12:15 AM
    trade_pro101 trade_pro101 Mar 27, 2015 10:45 PM Flag

    No I didn't e-mail Lorne regarding share buybacks yet. I e-mailed him before about the reserve life of the mines and he led me to some good sections on the website. He'll never give info that's not public obviously... or it's insider trading. You mentioned there is a public listing to find out though... so he should be able to give that info. SVM held ground well today compared to majority of other miners down but SVM up. I used to watch too closely on a day to day basis, like that time SVM dropped but the other miners rallied. But then days like today where SVM is in the green but many others down. It seems like the bad days are averaged out by upside correction days. I sometimes wonder how much pull we have on SVM with these message boards... because I noticed in the corporate presentation that SVM is 60% Retail Owned! Message Boards would have more influence if lots of retail investors that make emotional decisions. So I always like to get on these boards when invested.

    Sentiment: Strong Buy

  • trade_pro101 by trade_pro101 Mar 27, 2015 12:15 AM Flag

    AV... not only relying on the company believing it's undervalued... but based on Warren Buffet parameters. Warren would also like Silver over Gold because Silver has Utility with 50% of demand for Industrial use to produce electronics and a growing Solar Power industry that requires Silver to produce the panels.

    SVM is one of the few miners with positive EPS, low cost production, decreasing AISC expected to be only $9.80 by 2016, and increasing production oulook. The lowest forward looking P/E. Most attractive value with the lowest EV/EVBITDA of 2.8. P/CF of under 4.0 , and Multiple to NAV of .30. Plus .60 Price to Book Value. All screaming out a buy and dividend paying like Warren likes. From a technical point, SVM decade peak to low a whopping 93% down for a fundamentally sound miner! Risk is also diversified because 45% of sales from Zinc and Lead and 55% from Silver.

    This message board doesn't allow links. But Google "Should Warren Buffet be Buying Gold Miners?" a good Forbes article listing SVM as a Top 5 Pick. Also the Corporate Slide Presentation on Silvercorp's website shows a lot of great fundamentals. Lorne the VP is great. I was impressed by a quick reply to a question before. I'm happy to hold this stock long-term to ride the inevitable sector rebound!

    Sentiment: Strong Buy

  • trade_pro101 trade_pro101 Mar 24, 2015 5:23 PM Flag

    The positive news is not only about the actual buy back moving prices, but the fact companies usually don't do such a program unless the share price is way undervalued. With Silver averaging high since January, the next quarter report will be higher EPS. Even with a worst scenario annual $.10 EPS at 20X P/E, SVM should at minimum be $2.00.

    The Company is taking this action because it believes that prevailing market conditions have resulted in Silvercorp's shares being undervalued relative to the immediate and long term value of Silvercorp's portfolio of producing and development properties in China.

    Sentiment: Strong Buy

  • trade_pro101 trade_pro101 Mar 24, 2015 5:15 PM Flag

    How do you know zero shares were bought back since the December 2014 announcement?

    Sentiment: Strong Buy

  • trade_pro101 trade_pro101 Mar 24, 2015 4:03 PM Flag

    Very good news. I went long a few weeks ago without even realizing that positive fact. That means they'll be buying back this year 10% of the 171 Million Total Share Float!

    Sentiment: Strong Buy

  • April 2006: SVM $6.61 high (on the American side) Spot Silver: $14.57 high.
    November 2014: SVM $1.04 low (on the American side) Spot Silver: $14.15 low.
    Can you see the manipulation there for a miner with positive EPS and EV/EBITDA of 2.8! The best value for the share price!

    Sentiment: Strong Buy

  • trade_pro101 trade_pro101 Mar 21, 2015 6:21 PM Flag

    Redhaw... it looks like I was right. Had it trended up to $10.00 I would have missed the boat though. But I find once a Head & Shoulders begins to take form to the downside, the large investors realize this and stay away. I love technical analysis because you don't become a victim to pumpers. Don't get me wrong... I think Afrezza is the best thing since sliced bread since I'm Type 1 Diabetic, but there's a lot of fear in the air on whether Type 2's (the majority of diabetics) will embrace Afrezza as a Pre-Diabetes therapy and for sever Type 2's. There's no urgency for Type 2's to try it right away. For Type 1's we're excited to try it fast because our blood sugars are so out of whack we have nothing to lose. But the population of Type 1 is small compared to type 2. So the shorts realize it will take time to convert many type 2's over to try Afrezza. So they have until the next quarter report or the one after to keep shorting it. However, there could be some short squeeze news such as multiple applications to other countries at the same time. I'm from Canada and actually e-mailed Sanofi about when they plan to apply in Canada. He was afraid to give specific details, but mentioned they plan to apply to many countries. Meaning they don't want to apply one at a time like Canada this month and U.K. next month etc. I think behind the scenes they're working for one massive multi-country application for approval. And this is possible to be done very fast all at once because of Sanofi's global presence with Lantus. So I'm not only about technical analysis and see the fundamentals here. I'd love to buy back in at MNKD $4.00.

  • I don't think the shorts are gonna run to cover until $3.00 to $4.00 because worry is still in the air regarding sales numbers which won't be out until Q1 Report early May. I think it could hit $3.00 because that's the lower band of the Bollinger Band on the monthly chart, plus a Head & Shoulders pattern final bottom run. Technical analysis shows $3.00 is possible, especially with no news or numbers until Q1 Report in 2 months. Believe me... I love the product being a type 1 diabetic myself... but I'm putting my Trader Hat on. Can't try the product yet since I'm up in Canada.

  • trade_pro101 by trade_pro101 Mar 3, 2015 11:22 AM Flag

    My gut feeling was to stay away and that one more blood bath would happen before a long-term rally. Glad I stayed away. Will load the boat at $3.00 ;)

    Sentiment: Strong Sell

  • trade_pro101 trade_pro101 Feb 27, 2015 1:18 PM Flag

    Who's to say the lowest it can go is $6.00. I can see it dragging down to $4.00 as fear about low prescription numbers continue.

  • Reply to

    Only 100 prescriptions written? What a joke!

    by kawk_juice Feb 27, 2015 11:15 AM
    trade_pro101 trade_pro101 Feb 27, 2015 1:12 PM Flag

    I agree. That's not enough for a blockbuster drug. Just imagine if Viagra only had that many prescriptions first few weeks of launch!

  • Reply to

    About the only thing I'm sure of is this

    by matese16 Feb 27, 2015 12:31 PM
    trade_pro101 trade_pro101 Feb 27, 2015 1:07 PM Flag

    The only thing we are sure of... is the share price is going down.

  • Reply to


    by colton_s_mom Feb 26, 2015 10:28 AM
    trade_pro101 trade_pro101 Feb 26, 2015 10:33 AM Flag

    I agree. Its all Coltons fault.

  • trade_pro101 trade_pro101 Feb 26, 2015 10:22 AM Flag

    I think you're... sometime end of the year. But my problem was waiting on it as dead money until then. I've been holding gold mining and it rallied hard the last few days. The problem with holding for a buy out is the lost opportunity cost until then. My plan is to hold Yamana Gold AUY until a strong rebound is done with and then quickly jump on board MNKD to wait. Of course I do take the risk of a surprise sooner buy out. I would like to get back in before the next Q1 Report. Have a feeling there'll be a good rally after that one.

  • Ha.. ha..ha... I knew it wouldn't just for the fact everyone thought it would. Short Squeezes usually take people by surprise. Otherwise.... everyone would be rich.

  • Reply to

    Longs In Trouble This Morning ...

    by trade_pro101 Feb 24, 2015 4:09 AM
    trade_pro101 trade_pro101 Feb 25, 2015 5:56 AM Flag

    Big... big... trouble Longs. Price is same as close price in pre-market.

  • trade_pro101 trade_pro101 Feb 25, 2015 5:52 AM Flag

    How is it priced compared to Humalog insulin? Is the claim I read a few weeks ago about it being twice the cost per equivalent unit true? As small as that problem seems, it could become a problem as drug insurance companies might only cover half and say it's not necessary rather a luxury of better blood sugar control, to use Humalog. I know during the conference call MNKD was starting to short squeeze just above $7.00, but then something said near the end of the conference call caused it to crash back down. I think it might have been that statement that their having trouble getting the drug insurance companies on board to cover it all. I'm type 1 diabetic... so I know the benefit of ultra-rapid is definitely worth twice the money, but I don't know how a type 2 diabetic would view paying that much if they can use pills and natural remedies like Chromium, Alpha Lipoic Acid, and Seaweed extract. The drug insurance companies don't really care about the patient. The positive of it costing more would be more profits for MannKind, even if less sales because of it.

4.66+0.07(+1.53%)12:57 PMEDT